Cesarean Section; Complications, Wound, Infection (Following Delivery) Completed Phase 2 / 3 Trials for Nefopam (DB12293)

IndicationStatusPhase
DBCOND0113263 (Cesarean Section; Complications, Wound, Infection (Following Delivery))Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03626753Comparison of Two Routes of Administration of a Multimodal Analgesic Protocol in Postoperative Cesarean SectionTreatment